Published in Curr Opin Cardiol on September 01, 2002
Exercise training during diabetes attenuates cardiac ryanodine receptor dysregulation. J Appl Physiol (1985) (2009) 1.14
Hormesis does not make sense except in the light of TOR-driven aging. Aging (Albany NY) (2011) 1.10
Exercise training reduces cardiac angiotensin II levels and prevents cardiac dysfunction in a genetic model of sympathetic hyperactivity-induced heart failure in mice. Eur J Appl Physiol (2009) 1.09
Exercise training restores cardiac protein quality control in heart failure. PLoS One (2012) 1.06
Mild exercise training, cardioprotection and stress genes profile. Eur J Appl Physiol (2007) 0.98
Gene expression profile of rat left ventricles reveals persisting changes following chronic mild exercise protocol: implications for cardioprotection. BMC Genomics (2009) 0.89
Exercise training initiated after the onset of diabetes preserves myocardial function: effects on expression of beta-adrenoceptors. J Appl Physiol (1985) (2008) 0.88
Role of β-adrenergic receptors and nitric oxide signaling in exercise-mediated cardioprotection. Physiology (Bethesda) (2013) 0.87
Chronic exercise downregulates myocardial myoglobin and attenuates nitrite reductase capacity during ischemia-reperfusion. J Mol Cell Cardiol (2013) 0.85
Effects of aging and exercise training on apoptosis in the heart. J Exerc Rehabil (2013) 0.85
Myocardial tolerance to ischemia-reperfusion injury, training intensity and cessation. Eur J Appl Physiol (2010) 0.84
Exercise does not increase cyclooxygenase-2 myocardial levels in young or senescent hearts. J Physiol Sci (2010) 0.82
Delta opioid receptors: the link between exercise and cardioprotection. PLoS One (2014) 0.78
Effects of age increment and 36-week exercise training on antioxidant enzymes and apoptosis in rat heart tissue. J Sports Sci Med (2007) 0.78
Exercise and cardiac preconditioning against ischemia reperfusion injury. Curr Cardiol Rev (2013) 0.78
Body Composition, Lipid Profile, Adipokine Concentration, and Antioxidant Capacity Changes during Interventions to Treat Overweight with Exercise Programme and Whole-Body Cryostimulation. Oxid Med Cell Longev (2015) 0.77
Polymorphisms in the calcineurin genes are associated with the training responsiveness of cardiac phenotypes in Chinese young adults. Eur J Appl Physiol (2010) 0.77
Mechanisms Involved in Exercise-Induced Cardioprotection: A Systematic Review. Arq Bras Cardiol (2015) 0.76
Exercise Training Attenuates Upregulation of p47(phox) and p67(phox) in Hearts of Diabetic Rats. Oxid Med Cell Longev (2016) 0.75
Exercise training provides cardioprotection by activating and coupling endothelial nitric oxide synthase via a β3-adrenergic receptor-AMP-activated protein kinase signaling pathway. Med Gas Res (2017) 0.75
Prevalence of Takotsubo cardiomyopathy in the United States. Am Heart J (2012) 3.15
Mechanical ventilation-induced diaphragmatic atrophy is associated with oxidative injury and increased proteolytic activity. Am J Respir Crit Care Med (2002) 2.99
Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells. Circ Res (2003) 2.08
Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation (2004) 2.07
The Effect of Metformin Use on Left Ventricular Ejection Fraction and Mortality Post-Myocardial Infarction. Cardiovasc Drugs Ther (2015) 2.00
Dietary recommendations in the prevention and treatment of coronary heart disease: do we have the ideal diet yet? Am J Cardiol (2004) 1.74
Modulation of angiotensin II-mediated hypertension and cardiac remodeling by lectin-like oxidized low-density lipoprotein receptor-1 deletion. Hypertension (2008) 1.58
Effect of Joint National Committee VII report on hospitalizations for hypertensive emergencies in the United States. Am J Cardiol (2011) 1.58
Relation of microalbuminuria and coronary artery disease in patients with and without diabetes mellitus. Am J Cardiol (2006) 1.56
Multislice computed tomography in an asymptomatic high-risk population. Am J Cardiol (2006) 1.54
Assessment of left ventricular function: comparison of cardiac multidetector-row computed tomography with two-dimension standard echocardiography for assessment of left ventricular function. Int J Cardiovasc Imaging (2007) 1.49
Glucagon-like peptide-1 receptor agonist liraglutide inhibits endothelin-1 in endothelial cell by repressing nuclear factor-kappa B activation. Cardiovasc Drugs Ther (2013) 1.48
Resistance exercise and physical performance in adults aged 60 to 83. J Am Geriatr Soc (2002) 1.43
Adherence junction proteins in angiogenesis: modulation by aspirin and salicylic acid. J Cardiovasc Med (Hagerstown) (2012) 1.42
Eicosapentanoic acid inhibits hypoxia-reoxygenation-induced injury by attenuating upregulation of MMP-1 in adult rat myocytes. Cardiovasc Res (2003) 1.41
LOX-1 mediates oxidized low-density lipoprotein-induced expression of matrix metalloproteinases in human coronary artery endothelial cells. Circulation (2003) 1.40
Angiotensin II regulation of collagen type I expression in cardiac fibroblasts: modulation by PPAR-gamma ligand pioglitazone. Hypertension (2004) 1.38
High-risk acute coronary syndrome patient and cardiac biomarkers in the emergency department: where do we stand? Eur Heart J (2007) 1.38
Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II. Circ Res (2004) 1.35
Oxidized LDL, LOX-1 and atherosclerosis. Cardiovasc Drugs Ther (2011) 1.33
Oxidative stress in cardiovascular disease: molecular basis of its deleterious effects, its detection, and therapeutic considerations. Curr Opin Cardiol (2004) 1.28
Assessing the credibility of the "YouTube approach" to health information on acute myocardial infarction. Clin Cardiol (2012) 1.26
Dietary antioxidants and exercise. J Sports Sci (2004) 1.26
Small concentrations of oxLDL induce capillary tube formation from endothelial cells via LOX-1-dependent redox-sensitive pathway. Arterioscler Thromb Vasc Biol (2007) 1.24
Oxidized LDL, a critical factor in atherogenesis. Cardiovasc Res (2005) 1.22
In vivo and in vitro studies support that a new splicing isoform of OLR1 gene is protective against acute myocardial infarction. Circ Res (2005) 1.20
Regulatory role of endothelium in the expression of genes affecting arterial calcification. Biochem Biophys Res Commun (2004) 1.20
Exercise, antioxidants, and HSP72: protection against myocardial ischemia/reperfusion. Free Radic Biol Med (2003) 1.18
Association of scavenger receptors in adipose tissue with insulin resistance in nondiabetic humans. Arterioscler Thromb Vasc Biol (2009) 1.17
Oxidant stress in mitochondrial DNA damage, autophagy and inflammation in atherosclerosis. Sci Rep (2013) 1.17
Current Concepts of the Role of Oxidized LDL Receptors in Atherosclerosis. Curr Atheroscler Rep (2012) 1.16
Regulation of autophagy and apoptosis in response to ox-LDL in vascular smooth muscle cells, and the modulatory effects of the microRNA hsa-let-7 g. Int J Cardiol (2013) 1.15
Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance. Circ Cardiovasc Imaging (2010) 1.14
Cross-talk between dyslipidemia and renin-angiotensin system and the role of LOX-1 and MAPK in atherogenesis studies with the combined use of rosuvastatin and candesartan. Atherosclerosis (2005) 1.14
Loss of exercise-induced cardioprotection after cessation of exercise. J Appl Physiol (1985) (2003) 1.12
MicroRNA-29, a mysterious regulator in myocardial fibrosis and circulating miR-29a as a biomarker. J Am Coll Cardiol (2014) 1.12
Effect of statins on fasting plasma glucose in diabetic and nondiabetic patients. J Investig Med (2009) 1.12
Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy. Am J Med Sci (2011) 1.12
Common carotid artery wall thickness and external diameter as predictors of prevalent and incident cardiac events in a large population study. Cardiovasc Ultrasound (2007) 1.12
Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1. J Pharmacol Exp Ther (2002) 1.10
Oxidative posttranslational modifications mediate decreased SERCA activity and myocyte dysfunction in Galphaq-overexpressing mice. Circ Res (2010) 1.10
Inhibition of atherogenesis in LDLR knockout mice by systemic delivery of adeno-associated virus type 2-hIL-10. Atherosclerosis (2005) 1.10
LOX-1, an oxidized LDL endothelial receptor, induces CD40/CD40L signaling in human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol (2003) 1.08
Effect of exercise training on endothelial function in men with coronary artery disease. Am J Cardiol (2004) 1.07
Oxidative stress and lectin-like ox-LDL-receptor LOX-1 in atherogenesis and tumorigenesis. Antioxid Redox Signal (2011) 1.07
Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulation. Blood Coagul Fibrinolysis (2003) 1.07
Exercise training provides cardioprotection against ischemia-reperfusion induced apoptosis in young and old animals. Exp Gerontol (2005) 1.06
Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome. Am J Cardiol (2007) 1.06
ALDH2 protects against stroke by clearing 4-HNE. Cell Res (2013) 1.05
Common carotid arterial interadventitial distance (diameter) as an indicator of the damaging effects of age and atherosclerosis, a cross-sectional study of the Atherosclerosis Risk in Community Cohort Limited Access Data (ARICLAD), 1987-89. Cardiovasc Ultrasound (2006) 1.05
TGF-beta 1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregulation of MMP-1. Am J Physiol Heart Circ Physiol (2003) 1.05
Human cytomegalovirus inhibits Akt-mediated eNOS activation through upregulating PTEN (phosphatase and tensin homolog deleted on chromosome 10). Cardiovasc Res (2005) 1.04
Anoxia-reoxygenation stimulates collagen type-I and MMP-1 expression in cardiac fibroblasts: modulation by the PPAR-gamma ligand pioglitazone. J Cardiovasc Pharmacol (2004) 1.03
LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet. Cardiovasc Res (2008) 1.00
Angiotensin II induces capillary formation from endothelial cells via the LOX-1 dependent redox-sensitive pathway. Hypertension (2007) 0.98
Cholesterol-induced membrane microvesicles as novel carriers of damage-associated molecular patterns: mechanisms of formation, action, and detoxification. Arterioscler Thromb Vasc Biol (2012) 0.98
LOX-1 inhibition in myocardial ischemia-reperfusion injury: modulation of MMP-1 and inflammation. Am J Physiol Heart Circ Physiol (2002) 0.97
Oxidized LDL receptor 1 (OLR1) as a possible link between obesity, dyslipidemia and cancer. PLoS One (2011) 0.97
Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med (2015) 0.96
Interactions between the renin-angiotensin system and dyslipidemia: relevance in the therapy of hypertension and coronary heart disease. Arch Intern Med (2003) 0.96
Role of oxidative stress in coronary heart disease. Indian Heart J (2004) 0.95
LOX-1, oxidative stress and inflammation: a novel mechanism for diabetic cardiovascular complications. Cardiovasc Drugs Ther (2011) 0.95
Comparison of outcomes of weekend versus weekday admissions for atrial fibrillation. Am J Cardiol (2012) 0.95
Resistance exercise training attenuates exercise-induced lipid peroxidation in the elderly. Eur J Appl Physiol (2002) 0.95
Determining the significance of side branch lesion during bifurcation stenting. Am J Cardiol (2011) 0.95
MnSOD antisense treatment and exercise-induced protection against arrhythmias. Free Radic Biol Med (2004) 0.94
Regulation of TGFbeta1-mediated collagen formation by LOX-1: studies based on forced overexpression of TGFbeta1 in wild-type and lox-1 knock-out mouse cardiac fibroblasts. J Biol Chem (2008) 0.93
LOX-1 abrogation reduces myocardial ischemia-reperfusion injury in mice. J Mol Cell Cardiol (2007) 0.93
Angiotensin II-mediated oxidative stress and procollagen-1 expression in cardiac fibroblasts: blockade by pravastatin and pioglitazone. Am J Physiol Heart Circ Physiol (2006) 0.93
Triad of metabolic syndrome, chronic kidney disease, and coronary heart disease with a focus on microalbuminuria death by overeating. J Am Coll Cardiol (2011) 0.93
LOX-1 deletion alters signals of myocardial remodeling immediately after ischemia-reperfusion. Cardiovasc Res (2007) 0.93
Expression of lectin-like oxidized low-density lipoprotein receptors during ischemia-reperfusion and its role in determination of apoptosis and left ventricular dysfunction. J Am Coll Cardiol (2003) 0.92
Intracellular signaling of LOX-1 in endothelial cell apoptosis. Circ Res (2009) 0.92
Cannabinoids and atherosclerotic coronary heart disease. Clin Cardiol (2012) 0.92
Generation of robust cytotoxic T lymphocytes against prostate specific antigen by transduction of dendritic cells using protein and recombinant adeno-associated virus. Cancer Immunol Immunother (2007) 0.92
Over-expression of angiotensin II type 2 receptor (agtr2) reduces atherogenesis and modulates LOX-1, endothelial nitric oxide synthase and heme-oxygenase-1 expression. Atherosclerosis (2007) 0.92
Modulation of ADP-induced platelet activation by aspirin and pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling. J Pharmacol Exp Ther (2007) 0.92
Aging, exercise, and cardioprotection. Ann N Y Acad Sci (2004) 0.91
Molecular dissection of angiotensin II-activated human LOX-1 promoter. Arterioscler Thromb Vasc Biol (2006) 0.91
Prevention of heart failure. Curr Opin Cardiol (2006) 0.91
DPP-4 inhibitors repress NLRP3 inflammasome and interleukin-1beta via GLP-1 receptor in macrophages through protein kinase C pathway. Cardiovasc Drugs Ther (2014) 0.90
B-mode ultrasound common carotid artery intima-media thickness and external diameter: cross-sectional and longitudinal associations with carotid atherosclerosis in a large population sample. Cardiovasc Ultrasound (2008) 0.90
Aspirin inhibits oxidant stress, reduces age-associated functional declines, and extends lifespan of Caenorhabditis elegans. Antioxid Redox Signal (2012) 0.90
LOX-1 and angiotensin receptors, and their interplay. Cardiovasc Drugs Ther (2011) 0.90
Prior exposure to oxidized low-density lipoprotein limits apoptosis in subsequent generations of endothelial cells by altering promoter methylation. Am J Physiol Heart Circ Physiol (2011) 0.90
Interaction of oxidized low-density lipoprotein and the renin-angiotensin system in coronary artery disease. Curr Hypertens Rep (2006) 0.90
Curcumin reduces angiotensin II-mediated cardiomyocyte growth via LOX-1 inhibition. J Cardiovasc Pharmacol (2010) 0.89
Oxidized LDL triggers pro-oncogenic signaling in human breast mammary epithelial cells partly via stimulation of MiR-21. PLoS One (2012) 0.89
Anti-LOX-1 therapy in rats with diabetes and dyslipidemia: ablation of renal vascular and epithelial manifestations. Am J Physiol Renal Physiol (2007) 0.89
Effect of fish oils containing different amounts of EPA, DHA, and antioxidants on plasma and brain fatty acids and brain nitric oxide synthase activity in rats. Ups J Med Sci (2009) 0.89
In vivo flow cytometry of circulating clots using negative photothermal and photoacoustic contrasts. Cytometry A (2011) 0.89
Over-expression of angiotensin II type 2 receptor (agtr2) decreases collagen accumulation in atherosclerotic plaque. Biochem Biophys Res Commun (2007) 0.89
Does carotid intima media thickness indicate coronary atherosclerosis? Curr Opin Cardiol (2002) 0.88
Concentration polarization of ox-LDL activates autophagy and apoptosis via regulating LOX-1 expression. Sci Rep (2013) 0.88
The neighborhood where you live is a risk factor for stroke. Circ Cardiovasc Qual Outcomes (2013) 0.88
Deletion of LOX-1 attenuates renal injury following angiotensin II infusion. Kidney Int (2009) 0.88
Large impact of low concentration oxidized LDL on angiogenic potential of human endothelial cells: a microarray study. PLoS One (2012) 0.87
Regulation of autophagy and apoptosis in response to angiotensin II in HL-1 cardiomyocytes. Biochem Biophys Res Commun (2013) 0.87